# Parvovirus B19 Infection Presenting as Acute Tubulointerstitial Nephritis in an Immunocompetent Patient: A Case Report

**Authors:** Selim Benhadda, Yassir Tahri, Loubna Benamar, Naima Ouzeddoun, Tarik Bouattar

PMC · DOI: 10.7759/cureus.93576 · 2025-09-30

## TL;DR

A 21-year-old woman with no immune issues developed kidney failure due to parvovirus B19, highlighting the rare but important link between this virus and kidney disease.

## Contribution

This case report highlights parvovirus B19 as a rare cause of acute tubulointerstitial nephritis in immunocompetent adults.

## Key findings

- Renal biopsy confirmed acute tubulointerstitial nephritis without glomerular or vascular involvement.
- The patient's kidney function and inflammation markers improved spontaneously within three months.
- Positive PVB19 IgM, IgG, and viral DNA confirmed the infection as the cause of kidney injury.

## Abstract

A 21-year-old female patient with a history of Helicobacter pylori-associated gastritis and irregular menstrual cycles was admitted for fever, abdominal pain, vomiting, and stage 3 acute kidney injury (AKI). Three months earlier, she had presented with a pruritic rash and abdominal pain treated with amoxicillin-clavulanate, followed by recurrence of symptoms and deterioration. On admission, laboratory tests showed anemia, leukocytosis, thrombocytosis, elevated inflammatory markers, and mild proteinuria. An extensive infectious and autoimmune work-up was negative, except for positive IgM and IgG antibodies to parvovirus B19 (PVB19) and detectable viral DNA. Renal biopsy revealed acute tubulointerstitial nephritis without glomerular or vascular involvement. She was managed with supportive therapy, including hydration, antibiotics, and transfusion. Her renal function and clinical status progressively improved, with normalization of creatinine and inflammatory markers within three months. Although rare, PVB19 infection can present as acute interstitial nephritis even in immunocompetent adults. Recognition of this atypical presentation is crucial to avoid unnecessary immunosuppression and to anticipate spontaneous recovery.

## Linked entities

- **Chemicals:** amoxicillin-clavulanate (PubChem CID 6435924)
- **Diseases:** acute kidney injury (MONDO:0002492), anemia (MONDO:0002280), acute tubulointerstitial nephritis (MONDO:0800337)

## Full-text entities

- **Diseases:** Parvovirus B19 Infection (MESH:D016731), abdominal pain (MESH:D015746), vomiting (MESH:D014839), leukocytosis (MESH:D007964), anemia (MESH:D000740), proteinuria (MESH:D011507), Tubulointerstitial Nephritis (MESH:D009395), gastritis (MESH:D005756), AKI (MESH:D058186), infection (MESH:D007239), pruritic rash (MESH:D005076), fever (MESH:D005334), thrombocytosis (MESH:D013922), inflammatory (MESH:D007249)
- **Chemicals:** creatinine (MESH:D003404), amoxicillin-clavulanate (MESH:D019980)
- **Species:** Human parvovirus B19 (no rank) [taxon 10798], Homo sapiens (human, species) [taxon 9606], Helicobacter pylori (species) [taxon 210]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12574966/full.md

---
Source: https://tomesphere.com/paper/PMC12574966